HomeInsightsResults

Caplin Point Laboratories Ltd Quarterly Result

Caplin Point Laboratories Ltd Quarterly Result

stocks purchased

₹ 1.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

5.1 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

Net Profit

₹ 130.81

Last updated on: Nov 24, 2024

Key Highlights

  • The revenue of Caplin Point Laboratories Ltd for the Sep '24 is ₹ 503.87 crore as compare to the Jun '24 revenue of ₹ 477.54 crore. This represent the growth of 5.513671%.
  • The ebitda of Caplin Point Laboratories Ltd for the Sep '24 is ₹ 185.43 crore as compare to the Jun '24 ebitda of ₹ 170.39 crore. This represent the growth of 8.826805%.
  • The net profit of Caplin Point Laboratories Ltd for the Sep '24 is ₹ 130.81 crore as compare to the Jun '24 net profit of ₹ 124.92 crore. This represent the growth of 4.7150173%.

Results Analysis

Market Price of Caplin Point Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Caplin Point Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241964.95
21 Nov 20241943.5
19 Nov 20241951.3
18 Nov 20241985.35
14 Nov 20241952.65
13 Nov 20241952.95
12 Nov 20242009.45
11 Nov 20242010.35
08 Nov 20242010.85
07 Nov 20242117.5

Historical Revenue of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Caplin Point Laboratories Ltd News Hub

News

Caplin Point rises after Q2 PAT climbs 14% YoY to Rs 131 crore

Profit before tax (PBT) increased 15.38% YoY to Rs 168.46 crore in the quarter ended 30 Se...

Read more

07 Nov 202415:12

News

Caplin Point Laboratories to hold board meeting

Caplin Point Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

31 Oct 202412:06

News

Volumes jump at Caplin Point Laboratories Ltd counter

BASF India Ltd, Blue Dart Express Ltd, KFin Technologies Ltd, Welspun Living Ltd are among...

Read more

01 Oct 202414:30

News

Caplin Point hits life high after Chennai unit clears Brazilian Agency's inspection

ANVISA conducted an inspection of Caplin Steriles' injectable and ophthalmic manufacturing...

Read more

19 Aug 202409:46

News

Caplin Point Laboratories Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, Godfrey Phillips India Ltd, Gravita India Ltd and Poly Medicure ...

Read more

19 Aug 202412:00

News

Volumes spurt at Caplin Point Laboratories Ltd counter

Hindustan Zinc Ltd, Godfrey Phillips India Ltd, Angel One Ltd, Triveni Engineering and Ind...

Read more

19 Aug 202414:30

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Nov 2023

PPT

Feb 2023

PPT

Aug 2020

PPT

FAQ's For Caplin Point Laboratories Ltd Quarterly Result

What is the EPS of Caplin Point Laboratories Ltd stock?

The Earnings Per Share (EPS) of Caplin Point Laboratories Ltd is 64.93. An EPS is the amount of net income attributed to each share of a common stock.

How is Caplin Point Laboratories Ltd EPS calculated?

The EPS of Caplin Point Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Caplin Point Laboratories Ltd report its EPS?

Caplin Point Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Caplin Point Laboratories Ltd EPS?

Factors that influence the EPS of Caplin Point Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Caplin Point Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Caplin Point Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*